-
平臺(tái)編號(hào)：bio-135179
-
國(guó)際編號(hào)：DSM 26097
-
拉丁屬名： Intestinimonas butyriciproducens
-
規(guī)格：凍干粉/培養(yǎng)物
-
用途：DSM 原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu) 說明書
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
Intestinimonas butyriciproducens
Intestinimonas butyriciproducens
DSM 26097
BACTERIA
How to read the following data (Example)
Name:
Intestinimonas butyriciproducens Kl?ring et al. 2013
DSM No.:
26097
Strain designation:
AP4
Isolated from:
feces of female patient suffering from anorexia nervosa
Country:
France
Date of sampling:
01.2012
Nagoya Protocol Restrictions:
France requires a benefit-sharing declaration for French genetic resources at the time of utilization, i.e., conducting research. France considers access to genetic resources when utilization begins and not when the initial collection of the material took place and applies to material both in-situ and ex-situ and users within and outside of France.
To comply with French law, you, the user need to make a Declaration regarding access to genetic resources and benefit-sharing arising from your non-commercial utilisation of genetic resources. The steps are the following:
1. File a declaration via the CERFA form n. 15786 (https://www.formulaires.service-public.fr/gf/getAnnexe.do?cerfaAnnexe=1&cerfaFormulaire=15786*02) or by electronic procedure (https://www.demarches-simplifiees.fr/commencer/apa-declaration-pmorale)
2. Await approval by the Ministry for the Ecological Transition, the competent national authority
3. Respond to any requests for more information from the competent national authority
4. Receive an acknowledgment of receipt by the competent national authority certifying the prior informed consent (PIC) and establishment of mutually agreed terms (MAT) regarding benefit-sharing. This procedure shall not exceed 2 months.
For more information about this topic please see the Access and Benefit-Sharing Clearing House: https://absch.cbd.int/en/countries/FR
For more information about the commercial use of this genetic resources please contact: justiziariat@dsmz.de
History:
<- J.-C. Lagier, Timone Hospital, Marseille, France; AP4 (Clostridium anorexicus) <- A. Pfleiderer
Genbank accession numbers:
16S rRNA gene: JX101685
Cultivation conditions:
Medium 110 , 37°C
Medium/media recipe(s) required for preparing 110:
- Medium 78
Please follow special instructions: 'Cultivation of Anaerobes'
Complete DSMZ Media List
Summary and
additional information:
<- J.-C. Lagier, Timone Hospital, Marseille, France; AP4 (Clostridium anorexicus) <- A. Pfleiderer. Feces of female patient suffering from anorexia nervosa; France. Taxonomy/description (27078). Sequence accession no. 16S rRNA gene: JX101685. (Medium 110, 37°C, anaerobic).
Literature:
27078
Risk group:
1 (classification according to German TRBA)
Supplied as:
Delivery form Prices
DSM26097
DSM 26097
BACTERIA
How to read the following data (Example)
Name:
Intestinimonas butyriciproducens Kl?ring et al. 2013
DSM No.:
26097
Strain designation:
AP4
Isolated from:
feces of female patient suffering from anorexia nervosa
Country:
France
Date of sampling:
01.2012
Nagoya Protocol Restrictions:
France requires a benefit-sharing declaration for French genetic resources at the time of utilization, i.e., conducting research. France considers access to genetic resources when utilization begins and not when the initial collection of the material took place and applies to material both in-situ and ex-situ and users within and outside of France.
To comply with French law, you, the user need to make a Declaration regarding access to genetic resources and benefit-sharing arising from your non-commercial utilisation of genetic resources. The steps are the following:
1. File a declaration via the CERFA form n. 15786 (https://www.formulaires.service-public.fr/gf/getAnnexe.do?cerfaAnnexe=1&cerfaFormulaire=15786*02) or by electronic procedure (https://www.demarches-simplifiees.fr/commencer/apa-declaration-pmorale)
2. Await approval by the Ministry for the Ecological Transition, the competent national authority
3. Respond to any requests for more information from the competent national authority
4. Receive an acknowledgment of receipt by the competent national authority certifying the prior informed consent (PIC) and establishment of mutually agreed terms (MAT) regarding benefit-sharing. This procedure shall not exceed 2 months.
For more information about this topic please see the Access and Benefit-Sharing Clearing House: https://absch.cbd.int/en/countries/FR
For more information about the commercial use of this genetic resources please contact: justiziariat@dsmz.de
History:
<- J.-C. Lagier, Timone Hospital, Marseille, France; AP4 (Clostridium anorexicus) <- A. Pfleiderer
Genbank accession numbers:
16S rRNA gene: JX101685
Cultivation conditions:
Medium 110 , 37°C
Medium/media recipe(s) required for preparing 110:
- Medium 78
Please follow special instructions: 'Cultivation of Anaerobes'
Complete DSMZ Media List
Summary and
additional information:
<- J.-C. Lagier, Timone Hospital, Marseille, France; AP4 (Clostridium anorexicus) <- A. Pfleiderer. Feces of female patient suffering from anorexia nervosa; France. Taxonomy/description (27078). Sequence accession no. 16S rRNA gene: JX101685. (Medium 110, 37°C, anaerobic).
Literature:
27078
Risk group:
1 (classification according to German TRBA)
Supplied as:
Delivery form Prices
DSM26097
